Apogee Therapeutics Earnings

Apogee Therapeutics’s revenue jumped NaN% since last year same period to $0Mn in the Q3 2025. On a quarterly growth basis, Apogee Therapeutics has generated NaN% jump in its revenue since last 3-months.

Apogee Therapeutics’s net profit fell -32.65% since last year same period to $-65.02Mn in the Q3 2025. On a quarterly growth basis, Apogee Therapeutics has generated 1.63% jump in its net profits since last 3-months.

Apogee Therapeutics’s net profit margin jumped NaN% since last year same period to -Inf% in the Q3 2025. On a quarterly growth basis, Apogee Therapeutics has generated NaN% jump in its net profit margins since last 3-months.

Apogee Therapeutics’s earning per share (EPS) estimates for the current quarter stand at -0.62 - a -1.64% fall from last quarter’s estimates.

Apogee Therapeutics’s earning per share (EPS) estimates for the current year stand at -0.62.

Apogee Therapeutics’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q4 2025. This indicates that the Apogee Therapeutics has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.